China Medical Device Authority Restructured as NMPA

In March 2018, China restructured the medical device authority from China Food and Drug Administration (Known as CFDA) to National Medical Products Administration(Known as NMPA), it is administered by the State Administration for Market Regulation (Known as SAMR).

The new name NMPA shall be adapted from 1^st September 2018, it has been changed ‘CFDA’ to ‘NMPA’ in the medical device registration and approval system. Any registrants need to use the new name and its abbreviation of the China medical device authorities during the medical device registration in China.